AU2001269936A1 - Transgenic algae for delivering antigens to an animal - Google Patents

Transgenic algae for delivering antigens to an animal

Info

Publication number
AU2001269936A1
AU2001269936A1 AU2001269936A AU6993601A AU2001269936A1 AU 2001269936 A1 AU2001269936 A1 AU 2001269936A1 AU 2001269936 A AU2001269936 A AU 2001269936A AU 6993601 A AU6993601 A AU 6993601A AU 2001269936 A1 AU2001269936 A1 AU 2001269936A1
Authority
AU
Australia
Prior art keywords
animal
transgenic algae
delivering antigens
antigens
delivering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001269936A
Inventor
Carlos Farias
Richard T. Sayre
Surasak Siripornadulsil
Richard E. Wagner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ohio State University
Phycotransgenics LLC
Original Assignee
Ohio State University
Phycotransgenics LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ohio State University, Phycotransgenics LLC filed Critical Ohio State University
Publication of AU2001269936A1 publication Critical patent/AU2001269936A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0208—Specific bacteria not otherwise provided for
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/12—Unicellular algae; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • C12N15/8214—Plastid transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/517—Plant cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
    • A61K9/5068—Cell membranes or bacterial membranes enclosing drugs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/18011—Nimaviridae
    • C12N2710/18022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/18011—Nimaviridae
    • C12N2710/18034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Polymers & Plastics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Birds (AREA)
  • Animal Husbandry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Botany (AREA)
  • Physiology (AREA)
  • Insects & Arthropods (AREA)
  • Marine Sciences & Fisheries (AREA)
AU2001269936A 2000-06-20 2001-06-20 Transgenic algae for delivering antigens to an animal Abandoned AU2001269936A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21275700P 2000-06-20 2000-06-20
US60212757 2000-06-20
PCT/US2001/019643 WO2001098335A2 (en) 2000-06-20 2001-06-20 Transgenic algae for delivering antigens to an animal

Publications (1)

Publication Number Publication Date
AU2001269936A1 true AU2001269936A1 (en) 2002-01-02

Family

ID=22792303

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001269936A Abandoned AU2001269936A1 (en) 2000-06-20 2001-06-20 Transgenic algae for delivering antigens to an animal

Country Status (4)

Country Link
US (6) US20030022359A1 (en)
AU (1) AU2001269936A1 (en)
CL (1) CL2010001416A1 (en)
WO (1) WO2001098335A2 (en)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6932980B1 (en) * 2001-01-18 2005-08-23 Richard Sayre Method of making microalgal-based animal foodstuff supplements, microalgal-supplemented animal foodstuffs and method of animal nutrition
AU2001269936A1 (en) 2000-06-20 2002-01-02 Phycotransgenics, Llc Transgenic algae for delivering antigens to an animal
ATE467358T1 (en) 2001-03-23 2010-05-15 Advanced Bionutrition Corp METHOD FOR PRODUCING A FEED CONTAINING BACTERIA FOR AQUACULTURE AND ITS USE
US20090215179A1 (en) * 2001-07-20 2009-08-27 Transalgae Transgenically preventing establishment and spread of transgenic algae in natural ecosystems
US7807144B2 (en) 2001-09-05 2010-10-05 Academia Sinica Oral vaccines
US6872386B2 (en) * 2001-09-05 2005-03-29 Academia Sinica Oral vaccines
US20070148166A1 (en) * 2002-05-13 2007-06-28 Wu Madeline C S Scfvs in photosynthetic microbes
WO2004025263A2 (en) * 2002-09-16 2004-03-25 Advanced Bionutrition Corporation Protein and peptide expression for passive immunity
CA2537995A1 (en) * 2003-09-09 2005-03-17 Aquabounty Technologies, Inc. Compositions and methods for inhibiting white spot syndrome virus (wssv) infection
US7678561B2 (en) * 2006-05-09 2010-03-16 The Scripps Research Institute Robust expression of a bioactive mammalian protein in chlamydomonas chloroplast
US8216593B2 (en) * 2006-09-16 2012-07-10 Board Of Regents, The University Of Texas System Parasite vaccine
US20090088726A1 (en) * 2007-09-28 2009-04-02 Microsoft Corporation Symbiotic biological systems as platforms for sensing, production, and intervention
CN102099478A (en) * 2008-05-23 2011-06-15 马克思普朗克科学促进会 Generation of production strains that efficiently express nuclear transgenes
AU2009255947B2 (en) * 2008-06-06 2014-12-18 Aurora Algae, Inc. Vcp-based vectors for algal cell transformation
ES2475973T3 (en) * 2008-06-27 2014-07-11 Sapphire Energy, Inc. Induction of flocculation in photosynthetic organisms
US8367392B2 (en) * 2008-09-05 2013-02-05 Transalgae Ltd. Genetic transformation of algal and cyanobacteria cells by microporation
US20100183523A1 (en) * 2009-01-22 2010-07-22 Wagner Richard E Dental composition and method
EP2210582B1 (en) * 2009-01-22 2019-09-18 Solarvest Bioenergy Inc. Dental composition comprising algae and method for producing thereof
US8314228B2 (en) 2009-02-13 2012-11-20 Aurora Algae, Inc. Bidirectional promoters in Nannochloropsis
US8865468B2 (en) 2009-10-19 2014-10-21 Aurora Algae, Inc. Homologous recombination in an algal nuclear genome
US9029137B2 (en) 2009-06-08 2015-05-12 Aurora Algae, Inc. ACP promoter
US8809046B2 (en) 2011-04-28 2014-08-19 Aurora Algae, Inc. Algal elongases
WO2011011463A2 (en) * 2009-07-20 2011-01-27 Aurora Biofuels, Inc. Manipulation of an alternative respiratory pathway in photo-autotrophs
US20110081706A1 (en) * 2009-10-02 2011-04-07 TransAlgae Ltd Method and system for efficient harvesting of microalgae and cyanobacteria
US8822427B2 (en) 2010-10-27 2014-09-02 Harrisvaccines Methods and compositions to protect aquatic invertebrates from disease
US10004797B2 (en) 2010-10-27 2018-06-26 Harrisvaccines, Inc. Method of rapidly producing improved vaccines for animals
US8828961B2 (en) 2010-10-27 2014-09-09 Harrisvaccines Methods and compositions to protect aquatic invertebrates from disease
MY153741A (en) * 2010-11-10 2015-03-13 Univ Malaya A method for producing bio-active agent for the prevention of disease caused by white spot syndrome baculovirus complex and a bio-active agent derived thereof
MY161995A (en) * 2010-11-10 2017-05-31 Univ Malaya Vaccine against white spot syndrome virus
US8722359B2 (en) 2011-01-21 2014-05-13 Aurora Algae, Inc. Genes for enhanced lipid metabolism for accumulation of lipids
JP2014519810A (en) 2011-04-28 2014-08-21 オーロラ アルギー，インコーポレイテッド Algal desaturase
US9422347B2 (en) 2011-06-06 2016-08-23 The Regents Of The University Of California Algal produced malarial transmission blocking vaccines
EP2771453A4 (en) 2011-10-28 2015-07-08 Univ California Diatom-based vaccines
US8758774B2 (en) * 2012-07-20 2014-06-24 Kuwait Institute For Scientific Research Bivalent vaccine for marine fish and method for making the same
IN2015MN00403A (en) * 2012-08-23 2015-09-04 Transalgae Israel Ltd
DE102014200922A1 (en) * 2014-01-20 2015-07-23 Fim Biotech Gmbh Use of clay mineral as feed additive and / or as supplementary feed for aquatic organisms
US10480002B2 (en) 2014-02-12 2019-11-19 Transalgae Israel Ltd. Algal based edible vaccines
WO2015126992A1 (en) 2014-02-19 2015-08-27 The Regents Of The University Of California Colostrum/milk protein compositions
SG11201609039QA (en) 2014-05-04 2016-11-29 Forrest Innovations Ltd Compositions for mosquito control and uses of same
CN104946647A (en) * 2015-06-08 2015-09-30 南京理工大学 Chlamydomonas reinhardtii intergenic expression treating element
IL256387B2 (en) 2015-07-14 2023-03-01 Tarnsalgae Israel Ltd Transgenic microalgae and use thereof as a feed for delivery of interfering rna molecules
US10692126B2 (en) * 2015-11-17 2020-06-23 Nio Usa, Inc. Network-based system for selling and servicing cars
US10892942B2 (en) 2016-01-22 2021-01-12 Equinix, Inc. Container-based cloud exchange disaster recovery
GB201616087D0 (en) * 2016-09-21 2016-11-02 Tomalgae Cvba Algae comprising therapeutic and/or nutritional agents
CN113710268A (en) * 2019-03-29 2021-11-26 国立研究开发法人科学技术振兴机构 Drug delivery compositions
CN110117544A (en) * 2019-04-24 2019-08-13 中国热带农业科学院热带生物技术研究所 Can prevention and control grouper nervous necrosis Transgenic Microalgae, feed and application
CN110438054A (en) * 2019-07-26 2019-11-12 上海海洋大学 Vp19 transgenic blue algae and its purposes in preparation prevention and treatment shrimp white spot syndrome virus drug

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3678154A (en) 1968-07-01 1972-07-18 Procter & Gamble Oral compositions for calculus retardation
US3535421A (en) 1968-07-11 1970-10-20 Procter & Gamble Oral compositions for calculus retardation
IL70022A0 (en) * 1982-11-08 1984-01-31 Standard Oil Co Method for introducing foreign genes into green algae cells utilizing t-dna of agrobacterium
US4992207A (en) 1984-12-03 1991-02-12 Bio-Recovery Systems, Inc. Composition for extraction of metal ions and oxanions
GB8618374D0 (en) 1986-07-28 1986-09-03 Hsc Res Dev Corp Biological vascular prostheses
JPH0272881A (en) 1988-05-05 1990-03-13 Scripps Clinic Res Found Method and system for transformation of chlamydomonas reinhardtii
US4902508A (en) 1988-07-11 1990-02-20 Purdue Research Foundation Tissue graft composition
KR900701152A (en) * 1988-09-06 1990-12-01 원본미기재 Genetically Modified Plants, Compositions Obtained Therefrom, and Methods for Making the Same
US5804408A (en) * 1991-03-13 1998-09-08 Yoshihide Hagiwara Expression of human SOD in blue green algae
US6034298A (en) * 1991-08-26 2000-03-07 Prodigene, Inc. Vaccines expressed in plants
US5484719A (en) * 1991-08-26 1996-01-16 Edible Vaccines, Inc. Vaccines produced and administered through edible plants
US5612487A (en) * 1991-08-26 1997-03-18 Edible Vaccines, Inc. Anti-viral vaccines expressed in plants
US5281422A (en) 1991-09-24 1994-01-25 Purdue Research Foundation Graft for promoting autogenous tissue growth
US5670349A (en) * 1993-08-02 1997-09-23 Virginia Tech Intellectual Properties, Inc. HMG2 promoter expression system and post-harvest production of gene products in plants and plant cell cultures
US5661017A (en) * 1993-09-14 1997-08-26 Dunahay; Terri Goodman Method to transform algae, materials therefor, and products produced thereby
GB9414118D0 (en) * 1994-07-13 1994-08-31 Axis Genetics Ltd Modified plant viruses as vectors of heterologous peptides
US5871751A (en) * 1994-10-12 1999-02-16 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Renibacterium salmoninarum vaccine and method for its preparation
US5821087A (en) * 1995-03-30 1998-10-13 Merck & Co., Inc. Production of recombinant human papillomavirus type II protein utilizing papillomavirus 6/11 hybrid DNA
EP1018977B1 (en) 1995-05-26 2004-12-08 SurModics, Inc. Method and implantable article for promoting endothelialization
US5670191A (en) 1995-09-26 1997-09-23 Church & Dwight Co., Inc. Aliphatic amide feed supplement for ruminants
US5686125A (en) 1995-10-31 1997-11-11 Kalmbach Feeds, Inc. Granular anionic dry cow product
US5780448A (en) 1995-11-07 1998-07-14 Ottawa Civic Hospital Loeb Research DNA-based vaccination of fish
US6027900A (en) * 1996-04-12 2000-02-22 Carnegie Institution Of Washington Methods and tools for transformation of eukaryotic algae
JPH10150984A (en) 1996-11-19 1998-06-09 Hagiwara Yoshihide Production of antibody molecule
AU1075699A (en) 1997-10-10 1999-05-03 Allegheny Health, Education And Research Foundation Hybrid nanofibril matrices for use as tissue engineering devices
US6027715A (en) 1998-03-02 2000-02-22 Pozuelo; Jose Composition and means for treating dry mouth
AU4321999A (en) * 1998-05-28 1999-12-13 Ohio State University Research Foundation, The Organism and method for metal recovery, remediation and separation
US6265438B1 (en) 1998-12-03 2001-07-24 Heritage Technologies, Llc Vitamin compatible micronutrient supplement
US20030040809A1 (en) 1999-03-20 2003-02-27 Helmut Goldmann Flat implant for use in surgery
KR20000075076A (en) 1999-05-28 2000-12-15 최태진 A method for production of foreign protein using transformed microalgae
US6270347B1 (en) 1999-06-10 2001-08-07 Rensselaer Polytechnic Institute Nanostructured ceramics and composite materials for orthopaedic-dental implants
EP1114867A1 (en) 1999-12-27 2001-07-11 Universite De Geneve Transcription regulatory sequences derived from Chlamydomonas reinhardtii
KR100366608B1 (en) * 2000-02-15 2003-01-09 마스터진(주) Recombinant Human Papilloma Virus Vaccines expressed in transgenic plants
JP4189620B2 (en) 2000-03-01 2008-12-03 ライオン株式会社 Oral composition for periodontal disease prevention and treatment
US6932980B1 (en) 2001-01-18 2005-08-23 Richard Sayre Method of making microalgal-based animal foodstuff supplements, microalgal-supplemented animal foodstuffs and method of animal nutrition
AU2001269936A1 (en) * 2000-06-20 2002-01-02 Phycotransgenics, Llc Transgenic algae for delivering antigens to an animal
US6875907B2 (en) 2000-09-13 2005-04-05 Pioneer Hi-Bred International, Inc. Antimicrobial peptides and methods of use
US6805898B1 (en) 2000-09-28 2004-10-19 Advanced Cardiovascular Systems, Inc. Surface features of an implantable medical device
SE0003907D0 (en) 2000-10-27 2000-10-27 Swe Dencare Composition for the elimination of tartar from the mouth
NL1016779C2 (en) 2000-12-02 2002-06-04 Cornelis Johannes Maria V Rijn Mold, method for manufacturing precision products with the aid of a mold, as well as precision products, in particular microsieves and membrane filters, manufactured with such a mold.
US6703780B2 (en) 2001-01-16 2004-03-09 General Electric Company Organic electroluminescent device with a ceramic output coupler and method of making the same
US6709622B2 (en) 2001-03-23 2004-03-23 Romain Billiet Porous nanostructures and method of fabrication thereof
US6685956B2 (en) 2001-05-16 2004-02-03 The Research Foundation At State University Of New York Biodegradable and/or bioabsorbable fibrous articles and methods for using the articles for medical applications
AU2002257289A1 (en) 2001-05-17 2002-11-25 The Board Of Trustees Of The Leland Stanford Junior University Device and method for three-dimensional spatial localization and functional interconnection of different types of cells
FR2849596B1 (en) 2003-01-08 2005-02-11 Oreal COMPOSITION FOR THE TREATMENT OF ACNEIC TREND SKIN
KR101671394B1 (en) 2006-08-11 2016-11-01 유니버시티 오브 제네바 System, method and device for the expression or repression of proteins
US7465784B2 (en) 2006-10-26 2008-12-16 Board Of Regents Of The University Of Nebraska Antimicrobial peptides and methods of identifying the same

Also Published As

Publication number Publication date
WO2001098335A2 (en) 2001-12-27
US20170202940A1 (en) 2017-07-20
US7410637B2 (en) 2008-08-12
US20090098149A1 (en) 2009-04-16
US20140127254A1 (en) 2014-05-08
CL2010001416A1 (en) 2011-04-25
US20140017272A1 (en) 2014-01-16
WO2001098335A3 (en) 2002-05-16
US20030211089A1 (en) 2003-11-13
US20030022359A1 (en) 2003-01-30
US8282915B2 (en) 2012-10-09

Similar Documents

Publication Publication Date Title
AU2001269936A1 (en) Transgenic algae for delivering antigens to an animal
AU2001259803A1 (en) Animal shelter
AUPR003900A0 (en) An animal decoy
AU2002222610A1 (en) Transgenic animal expressing hla-a24 and utilization thereof
EP1452093A4 (en) Chimeric nonhuman animal
AU2001272408A1 (en) Growth promoter for animals
AU2001278919A1 (en) Transgenic animal and methods
AU5561301A (en) Transgenic animal
AU2001245574A1 (en) Fish bait device
AU2001275736A1 (en) Improvements in animal cages
AU2003237975A1 (en) Transgenic animal comprising intracellular immunoglobins for xenotransplantation
AU2001259670A1 (en) Animal harness
AU2001270497A1 (en) Fishing bait
AU2001259660A1 (en) Particulate feed for young poultry
AU2000252482A1 (en) Lure for fishing
AU2001269707A1 (en) Method for improving the efficacy of artificial insemination of non-human animals
GB2370485B (en) Canine halter
AU6675600A (en) Transgenic animals that produce altered wool
AU2001263890A1 (en) Hoof protector for horses
EP1224276A4 (en) Transgenic animal production using lopu-derived oocytes
AU2001252781A1 (en) Animal trap
AU2001277716A1 (en) Transgenic animal
GB2360435B (en) Animal feeder
EP1145630A2 (en) Cattle grooming device
AUPQ944200A0 (en) Humane animal lead